Adawi Kamal bought FATE
January 15, 2026 · Form 4 insider transaction
Adawi Kamal bought 25,000 shares of Fate Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderAdawi Kamal
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 15, 2026
Filing dateJanuary 16, 2026
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of restricted stock units ("RSUs") that vest with respect to 1/4th of the RSUs on each of January 8, 2027, January 8, 2028, January 8, 2029 and January 8, 2030, subject to the Reporting Person's continued service with the Issuer as of each such vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.